The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

White Paper: Scaling Hope: The Growth of the Allogeneic Cell Therapy Sector

Cell & Gene Therapy, News, Thought Leadership|

In the rapidly evolving landscape of advanced therapies, allogeneic cell therapies have emerged as a promising avenue for addressing various disorders, including hematological malignancies, neurological conditions, and autoimmune or inflammatory diseases. With a number of clinical trials underway to evaluate their efficacy, allogeneic cell therapies hold significant potential in reshaping the way we approach treating numerous diseases.

In this white paper, Anshul Mangal, President of Project Farma & Precision ADVANCE and John Khoury, Executive Vice President of Project Farma (PF), discuss the growth of the allogeneic cell therapy sector and its impact on patient access.


Conference: Association for Value-Based Cancer Care 2023 Educational Summit & Program

Cell & Gene Therapy, Events, Thought Leadership|

Precision’s Phil Cyr will be the presenting at this year’s Association for Value-Based Cancer Care 2023 Educational Summit & Program, October 18 – 20, NYC, NY. This exclusive invitational forum provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem.

Don’t miss an opportunity to celebrate groundbreaking science and network with industry leaders!

  • Be sure to attend Precision’s own, Phil Cyr’s presentation on October 18th, 2023, at 10:00 AM ET

You can register for the Association for Value-Based Cancer Care 2023 Educational Summit & Program:



Webinar: Rise of mRNA manufacturing

Cell & Gene Therapy, Events|

Sponsored by Project Farma, a Precision for Medicine Company, this panel will feature insights from industry leaders on the current state of the market for mRNA-based medicines, techniques to optimize manufacturing and technical operations, and strategies for CQV, quality, automation & engineering for mRNA facilities.

This discussion will be moderated by Anshul Mangal: President (Project Farma & Precision ADVANCE), and include insights from Aaron Allen: Director, Global Quality, External Engagement (Moderna), Andrew Geall: Co-founder and Chief Development Officer (Replicate Bioscience), Jane True: Global VP, mRNA Commercial Strategy Innovation & Pandemic Security Lead (Pfizer), Venkata Indurthi: CSO (Aldevron), and Chad Salisbury: SVP (Project Farma).


Conference: Meeting on the Mesa, 2023

Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Meeting on the Mesa, October 10-12, 2023, in Carlsbad, CA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for cell and gene therapies.

Connect with our Advanced Therapy experts

  • Visit us through any of the numerous networking opportunities at Meeting on the Mesa 23′
  • Be sure to attend the ADVANCE sponsored Plenary Session on October 10, 2023, 9:30 – 10:30 AM PT |Location: Park Hyatt Aviara (Aseptic Technologies Ballroom)
  • Join us for the ADVANCE sponsored Cocktail Reception on October 11, 2023, 6:00-7:00 PM PT

You can register for Meeting on the Mesa below:



Event: Endpoints 11, 2023

Cell & Gene Therapy, Events, Thought Leadership|

Precision is honored to be a sponsor of this year’s Endpoints 11 taking place on September 20, 2023, in Boston, MA. Join a select group of industry leaders for this year’s awards gala as we gather at the State Room in Downtown Boston for an evening of dinner, drinks and networking to meet the future of biotech.

Connect with our Advanced Therapy experts!

  • Date: Wednesday, September 20, 2023
  • Time: 5:30pm – 10:30 pm ET
  • Location: State Room, Boston, MA

CLICK HERE to reserve your spot.


Load More Posts